Sarissa Capital Management as of Dec. 31, 2016
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 44.0 | $160M | 13M | 12.44 | |
| Biogen Idec (BIIB) | 24.2 | $88M | 310k | 283.58 | |
| Medicines Company | 16.4 | $60M | 1.8M | 33.94 | |
| Innoviva (INVA) | 8.8 | $32M | 3.0M | 10.70 | |
| Noveliontherapeuti.. | 2.4 | $8.6M | 1.0M | 8.42 | |
| Intra Cellular Therapies (ITCI) | 1.5 | $5.4M | 360k | 15.09 | |
| Advaxis | 1.0 | $3.6M | 500k | 7.16 | |
| Vivus | 0.8 | $3.0M | 2.6M | 1.15 | |
| Apricus Biosciences | 0.5 | $1.9M | 1.4M | 1.30 | |
| AVEO Pharmaceuticals | 0.2 | $918k | 1.7M | 0.54 | |
| Abbvie (ABBV) | 0.2 | $626k | 10k | 62.60 |
